BreachRx SPV1, LLC is a venture capital fund based in Atlanta, Georgia. Its most recent Form D, filed Oct 3, 2025, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Overline, LLC.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Overline, LLC
- Latest Form D
- Oct 3, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about BreachRx SPV1, LLC
What is the minimum investment for BreachRx SPV1, LLC?
BreachRx SPV1, LLC's latest Form D, filed Oct 3, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in BreachRx SPV1, LLC?
BreachRx SPV1, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has BreachRx SPV1, LLC raised?
BreachRx SPV1, LLC's latest Form D, filed Oct 3, 2025, reports no sales yet.
Where is BreachRx SPV1, LLC based?
BreachRx SPV1, LLC is based in Atlanta, Georgia and is managed by Overline.
Size compared with every venture capital fund
This fund hasn't reported any sales yet.